ICICI Bank BUY. Performance Highlights. CMP Target Price `307 `411. 1QFY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

Similar documents
ICICI Bank BUY. Performance Highlights. CMP Target Price `328 `416. 3QFY2018 Result Update Banking. 3-year price chart. Key financials (Standalone)

ICICI Bank BUY. Performance Highlights. CMP Target Price `343 `460. Q3FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

HDFC Bank BUY. Operating performance strong; improved NIM. CMP `2,268 Target Price `2,500. Q4FY2019 Result Update Banking. 3-year price chart

HDFC Bank BUY. Performance Highlights. CMP `2,145 Target Price `2,500. Q3FY2019 Result Update Banking. 3-year price chart. Key financials (Standalone)

HDFC Bank BUY. Performance Highlights. CMP `1,965 Target Price `2,350. Q2FY2019 Result Update Banking. 3-year price chart. Exhibit 1: Key Financials

Axis Bank BUY. CMP Target Price `620 `750. Update Bank. Earnings to normalize with stabilizing credit costs. 3-year price chart.

Federal Bank BUY. Performance Highlights. Target Price. 1QFY2018 Result Update Banking. Stock Info Sector

ICICI Bank BUY. Performance Highlights. CMP Target Price `279 `348. 2QFY2016 Result Update Banking. 3-year price chart. Key financials (Standalone)

LIC Housing Finance BUY. Performance Highlights. CMP Target Price `532 `630. 3QFY2017 Result Update HFC. 3-Year Daily Price Chart

Dewan Housing Finance

Punjab National Bank NEUTRAL. Performance Highlights CMP. `134 Target Price - 2QFY2016 Result Update Banking November 13, Investment Period -

Yes Bank BUY. CMP Target Price `380 `435. Initiating Coverage Banking. Growth affirmed. 3-year price chart. Key Financials (Standalone)

RBL Bank BUY. CMP Target Price `573 `690. Quick take BANK. January 7, year price chart

Punjab National Bank ACCUMULATE. Performance Highlights. CMP `1,115 Target Price `1,259. 3QFY2011 Result Update Banking.

Amber Enterprises India Ltd

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

HFC NEUTRAL. Performance Highlights CMP. `678 Target Price - 1QFY2013 Result Update HFC. Investment Period - Key financials

HDFC Bank ACCUMULATE. Performance Highlights. CMP `2,348 Target Price `2,671. 4QFY2011 Result Update Banking. Key financials

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Allahabad Bank ACCUMULATE. Performance Highlights CMP. `142 Target Price `152. 2QFY2013 Result Update Banking. Investment Period 12 months

Maruti Suzuki India BUY. Performance Update. CMP `9,315 Target Price `10,820. 1QFY2019 Result Update Automobile. Historical share price chart

Mahindra & Mahindra Ltd.

Bata India BUY. Performance Update. CMP Target Price `842. 1QFY2019 Result Update Footwear. Historical share price chart.

Mahindra & Mahindra Ltd.

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Hindustan Media Ventures

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

Jammu and Kashmir Bank

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Music Broadcast BUY. Performance Update. CMP Target Price `293 `475. 3QFY2019 Result Update Media. Stock Info Sector Market Cap (Rs cr) Media

Bata India BUY. Performance Update. CMP `1,008 Target Price `1,243. 2QFY2019 Result Update Footwear. Historical share price chart.

Music Broadcast BUY. Performance Update. CMP Target Price `329 `475. 2QFY2019 Result Update Media. Historical share price chart.

Union Bank of India NEUTRAL. Performance Highlights CMP. `393 Target Price - 2QFY2011 Result Update Banking. Investment Period -

TV Today Network BUY. Performance Update CMP. `323 Target Price `498. 3QFY2019 Result Update Media. Investment Period 12 Months

Maruti Suzuki India BUY. Performance Update. CMP `6,705 Target Price `8,552. 2QFY2019 Result Update Automobile. Historical share price chart

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Goodyear India BUY. Company Update. CMP Target Price `515 `631. Company Update Tyres. 3-year Daily Price Chart. Key Financials

Syndicate Bank NEUTRAL. Performance Highlights CMP. `81 Target Price - 2QFY2014 Result Update Banking. Investment Period -

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Procter & Gamble Hygiene & Health Care

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Jammu and Kashmir Bank

Andhra Bank NEUTRAL. Performance Highlights CMP. `110 Target Price - 4QFY2012 Result Update Banking. Investment Period -

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

HDFC Bank NEUTRAL. Performance Highlights CMP. `511 Target Price - 1QFY2012 Result Update Banking. Investment Period - Key financials

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Jindal Steel & Power BUY. CMP Target Price `200 `320. 1QFY2019 Result Update Steel & Power. Performance Update

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

IndoStar Capital Finance Ltd.

Bank of Maharashtra NEUTRAL. Performance Highlights CMP. `47 Target Price - 1QFY2013 Result Update Banking. Investment Period - Key financials

REPCO Home Finance BUY. Reaping the benefits of serving the underserved. CMP Target Price `642 `825. Initiating Coverage HFC.

Bank of Maharashtra ACCUMULATE. Performance Highlights CMP. `48 Target Price `55. 4QFY2012 Result Update Banking. Investment Period 12 Months

Tata Consultancy Services (TCS)

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,226 Target Price `3,466. 3QFY2017 Result Update Automobile. 3-year price chart

HDFC Bank NEUTRAL. Performance Highlights CMP. `485 Target Price - 3QFY2012 Result Update Banking. Investment Period -

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 3QCY2017 Result Update Pharmaceutical. Investment Period 12 months

Oriental Bank of Commerce

Indian Bank NEUTRAL. Performance Highlights CMP. `178 Target Price - 2QFY2013 Result Update Banking. Investment Period - Key financials (Standalone)

Sanofi India NEUTRAL. Performance Highlights. CMP `4,007 Target Price - 2QCY2017 Result Update Pharmaceutical. 3-year price chart.

LT Foods BUY. Performance Update. CMP Target Price `92 `128. 3QFY2018 Result Update Media February 12, 2018

KEI Industries BUY. Performance Update. Target Price. 3QFY2018 Result Update Cable. Historical share price chart. Key Financials

Indian Overseas Bank ACCUMULATE. Performance Highlights. CMP Target Price `137 `155. 1QFY2012 Result Update Banking

BUY. Aditya Birla Capital Ltd CMP. `155 Target Price `218. Initiating Coverage Finance. March 9, Investment Period 12 Months.

Tech Mahindra ACCUMLATE. Performance Highlights `495 `526. CMP Target Price. 2QFY2018 Result Update IT

Mahindra & Mahindra Ltd.

The New India Assurance Company Ltd

LT Foods BUY. Performance Update. CMP Target Price `76 `128. 4QFY2018 Result Update Media

KEI Industries BUY. Performance Update. CMP Target Price `433 `508. 4QFY2018 Result Update Cable. Historical share price chart.

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

GAIL India NEUTRAL. Performance Highlights CMP. `363 Target Price - 2QFY2013 Result Update Oil & Gas. Investment Period -

HDFC Asset Management Co

Sanofi India NEUTRAL. Performance Highlights. CMP `4,301 Target Price - 4QCY2016 Result Update Pharmaceutical. Investment Period - 3-year price chart

Punjab National Bank BUY. Performance Highlights. CMP `1,066 Target Price `1,326. 4QFY2011 Result Update Banking. Key financials

Blue Star Ltd BUY. Performance Update. CMP Target Price `754 `867. 4QFY2018 Result Update Cons. Durable. 3-year price chart.

Hero MotoCorp ACCUMULATE. Performance Highlights. CMP `3,718 Target Price `4,130. 1QFY2018 Result Update Automobile. 3-year price chart

SpiceJet BUY. Performance Highlights CMP. `32 Target Price `43. 1QFY2013 Result Update Airlines. Investment Period 12 Months.

Cadila Healthcare NEUTRAL. Performance Highlights CMP. `495 Target Price - 4QFY2017 Result Update Pharmaceutical.

Quick take. Ashok Leyland Ltd BUY. Scrappage policy to drive faster growth. Target Price. Investment Period 12 Months. 3-year price chart

Century Plyboards Ltd

Sanofi India ACCUMULATE. Performance Highlights. CMP `4,410 Target Price `4,738. 1QCY2016 Result Update Pharmaceutical. 3-year price chart

Transport Corporation of India

ICICI Bank BUY. Performance Highlights. CMP `1,152 Target Price `1,352. 4QFY2013 Result Update Banking

Graphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months

CCL Products BUY. Performance Update. CMP Target Price `278 `360. 3QFY2018 Result Update Coffee. Historical share price chart.

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

Cairn India ACCUMULATE. Performance Highlights. CMP Target Price `338 `382. 2QFY2013 Result Update Oil & Gas. Quarterly highlights (Consolidated)

Quick take. VIP Industries BUY. Travelling smart on the luggage track. CMP Target Price `153 ` year daily price chart

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

Graphite India BUY. Performance Highlights. CMP Target Price `88 `109. 1QFY2012 Result Update Capital Goods

ICICI Bank BUY. Performance Highlights CMP. `928 Target Price `1,169. 1QFY2013 Result Update Banking. Investment Period 12 Months

Transcription:

Jul-15 Nov-15 Mar-16 Jul-16 Nov-16 Mar-17 Jul-17 Nov-17 Mar-18 Jul-18 1QFY2019 Result Update Banking July 30, 2018 ICICI Bank Performance Highlights Particulars (` cr) 3QFY18 2QFY18 % chg (qoq) 3QFY17 % chg (yoy) NII 6,102 6,022 1.3 5,590 9.2 Pre-prov. profit 5,808 7,513 (22.7) 5,184 12.0 PAT (120) 1,019-2,050 - ICICI Bank reported loss of `120cr owing to MTM losses (after IPru Life stake sale) and elevated provisions (increased coverage on NCLT exposure). Net interest income grew by 9.2% and reported NIM compressed by 5bps/8bps qoq/yoy to 3.19%. Slippage for Q1FY19 was `4,036cr, which is lowest from last 11 quarter. Healthy growth in retail advances; slippages at low During 1QFY19, the bank s advances grew by 11.3% yoy (0.6% qoq), aided by healthy retail loan book growth of 20% yoy. The main drivers leading to the growth in the retail loan book were Personal loans/credit card/business banking loan, which grew by 47.7%/27.9%/40.7 yoy respectively. Retail contribution to total loans increased to 57.5% as compared to 53.3% in the corresponding quarter of the previous year. The corporate loan book grew 5.4% yoy, declined 0.8% qoq. Deposits growth was modest at 12.5% yoy, while CASA deposits saw a growth of 16.1% yoy, resulting in improvement in CASA ratio by 157bps yoy to 50.5%. The reported NIM fell by 5bps/8bps qoq/yoy to 3.19%, with domestic NIM at 3.54% as compared to 3.67% in 4QFY18. On the asset quality front, the bank witnessed slippages during the quarter to the tune of `4,036cr, which were at multi quarter lows and largely driven by drill down list and existing addition to NPA (exchange fluctuation). The Gross NPA ratio declined 3bps sequentially to 8.81%, whereas the Net NPA declined 58bps qoq to 4.2% in Q1FY19. The bank has sequentially enhanced provision in NCLT-1 from 52.6% to 87.9% and in NCLT-2 from 47.8% to 6.7%. Total exposure (funded and Non- funded) stand at `14,300cr. Outlook & Valuation: At the current market price, the bank s core banking business (after adjusting value of subsidiaries) is trading at 1.16x FY20E ABV. We believe strength of liability franchise (CASA-50%), shift in loan mix towards retail assets and better rated companies, Strong capitalization (tier I of 14.42%), and steady improvement in stress loan and going forward quick resolution under IBC would be the key trigger for multiple expansion. We recommend a Buy rating on the stock, with a target price of `411. Key financials (Standalone) Y/E March (` cr) FY2017 FY2018 FY2019E FY2012E NII 21,738 23,025 26,781 30,126 % chg 2 6 16 12 Net profit 9,802 6,645 6,807 12,339 % chg 0.8 (32.2) 2.4 81 NIM (%) 3.2 3.1 3.2 3.3 EPS (`) 15 10 11 19 P/E (x) 20 30 29 16 P/ABV (x) 3 2 2 2 RoA (%) 1.3 0.8 0.7 1.2 RoE (%) 10 6 6 11 ; Note: CMP as of July 30, 2018 BUY CMP Target Price Investment Period Stock Info `307 `411 12 Months Sector Market Cap (` cr) Banking 1,97,635 Beta 1.6 52 Week High / Low 365.7/256 Avg. Daily Volume 13,74,077 Face Value (`) 2 BSE Sensex 37,494 Nifty 11,319 Reuters Code ICBK.NS Bloomberg Code ICICIBC@IN Shareholding Pattern (%) Promoters Please refer to important disclosures at the end of this report 1 NA MF / Banks / Indian Fls 31.7 FII / NRIs / OCBs 60.4 Indian Public / Others 7.7 Abs. (%) 3m 1yr 3yr Sensex 6.2 14.8 35.5 ICICI Bank 3.1 (2.9) 10.8 3-year price chart 400 350 300 250 200 150 100 Jaikishan Parmar Research Analyst 022 39357600 Ext: 6810 Jaikishan.parmar@angelbroking.com

Exhibit 1: quarterly results summary Particulars (` cr) 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 4QFY18 1QFY19 % YoY % QoQ Interest earned 13,639 13,618 13,569 13,459 13,577 13,665 14,264 14,722 9.4 3.2 - on Advances / Bills 9,905 9,870 9,991 9,847 10,090 10,238 10,690 10,982 11.5 2.7 - on investments 2,997 2,948 2,622 2,827 2,879 2,860 3,001 3,136 10.9 4.5 - on balance with RBI & others 38 126 282 199 145 154 166 227 14.1 36.5 - on others 699 675 674 586 463 412 406 378 (35.5) (7.0) Interest Expended 8,386 8,254 7,606 7,869 7,868 7,960 8,243 8,620 9.5 4.6 Net Interest Income 5,253 5,364 5,962 5,590 5,709 5,705 6,022 6,102 9.2 1.3 Other income 9,119 3,938 3,017 3,388 5,186 3,167 5,678 3,851 13.7 (32.2) - Fee income 2,356 2,495 2,446 2,377 2,570 2,639 2,755 2,754 15.9 (0.0) - Treasury income 6412 893 503 858 2193 66 2685 766 (10.7) (71.5) - Others 351 550 68 153 423 462 238 331 116.3 39.1 Operating income 14,372 9,302 8,979 8,978 10,895 8,872 11,700 9,953 10.9 (14.9) Operating expenses 3,736 3,778 3,867 3,794 3,909 3,814 4,186 4,145 9.3 (1.0) - Employee expenses 1,556 1,406 1,480 1,511 1,514 1,363 1,526 1,514 0.2 (0.8) - Other Opex 2,180 2,372 2,387 2,283 2,395 2,452 2,660 2,631 15.3 (1.1) Pre-provision Profit 10,636 5,524 5,112 5,184 6,986 5,057 7,513 5,808 12.0 (22.7) Provisions & Contingencies 7082 2713 2898 2609 4503 3570 6626 5971 128.9 (9.9) PBT 3,554 2,812 2,214 2,575 2,483 1,488 888 (164) - - Provision for Tax 451 369 189 526 425 (162.1) (131.8) (43.4) - - PAT 3,103 2,442 2,025 2,050 2,058 1,650 1,019 (120) - - Exhibit 2: Strong Retail lending supports Loan Growth Particulars (` cr) 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 4QFY18 1QFY19 % YoY % QoQ Domestic Corporate 1,29,921 1,26,735 1,24,372 1,31,316 1,35,949 132198 131137 5.4 (0.8) Overseas branches 82,802 74,741 71,468 71,934 70,754 64562 64536 (9.7) (0.0) SME 21,044 22,283 20,883 20,760 24,764 25620 23749 13.7 (7.3) Retail Total 2,23,703 2,40,472 2,47,352 2,58,770 2,73,920 291040 296866 20.0 2.0 Total 4,57,469 4,64,232 4,64,075 4,82,780 5,05,387 513420 516289 11.3 0.6 Loan Mix (%) Domestic Corporate 28 27 27 27 27 26 25 Overseas branches 18 16 15 15 14 13 13 SME 5 5 5 4 5 5 5 Retail Total 49 52 53.3 53.6 54.2 56.7 57.5 July 30, 2018 2

Exhibit 3: Slippages at multi quarter lows Particulars (` cr) Q3FY17 Q4FY17 Q1FY18 Q2FY18 Q3FY18 Q4FY18 Q1FY19 Opening gross NPA 32,548 38,085 42,552 43,148 44,489 46,039 54,063 Add: gross additions 7,037 11,289 4,976 4,674 4,380 15,737 4,036 slippages 1.54% 2.43% 1.07% 0.97% 0.87% 3.07% 0.78% Slippages Annulised 3.87% 3.47% 12.29% 3.13% - of which: slippages from Restructured assets 239 1,803 1,476 372 197 327 82 Drilldown 2,943 7,957 359 1,135 614 11,776 303 Existing NPA2 & non-fund 2,040 40 195 220 146 655 1,192 Loans under RBI resolution - 32 111 192 2,022 877 246 Less: recoveries & upgrades 625 1,413 2,775 1,029 1,108 4,234 2,036 % of Adv recoveries & upgrades 0.14% 0.30% 0.60% 0.21% 0.22% 0.83% 0.39% Net additions 6,412 9,876 2,201 3,645 3,272 11,503 2,000 Less: write-offs & sale 875 5,409 1,605 2,304 1,722 3,479 2,598 % of Adv recoveries & upgrades 0.19% 1.17% 0.35% 0.48% 0.34% 0.68% 0.50% Closing gross NPAs 38,085 42,552 43,148 44,489 46,039 54,063 53,465 GNPA (%) 7.20% 7.89% 8.0% 7.87% 7.82% 8.84% 8.81% Less - Provision 17,930 17,101 17,842 20,359 22,229 26,177 29,295 Net NPAs 20,155 25,451 25,306 24,130 23,810 27,886 24,170 Net NPA (%) 3.96% 4.89% 4.86% 4.43% 4.20% 4.77% 4.19% PCR (Calc) 47.08% 40.19% 41.35% 45.76% 48.28% 48.42% 54.79% Exhibit 4: Declining trend in stress loans Particulars (` cr) 4QFY16 1QFY17 2QFY17 3QFY17 4QFY17 1QFY18 2QFY18 3QFY18 4QFY18 1QFY19 Outstanding stock of bad loans 53,300 48,100 44,300 38,200 30,100 28,300 28,300 25,800 13,461 11,898 (% of loans) 12.2% 10.7% 9.8% 8.4% 6.5% 6.1% 5.9% 5.1% 2.6% 2.3% NPA Sub investment grade 44,100 38,700 32,500 27,500 19,000 20,400 19,600 19,100 4,728 4,401 Security receipts 600 2,200 2,800 2,800 3,300 3,400 3,500 3,400 3,438 3,438 Other dispensation 8,600 7,200 9,000 7,900 7,800 4,500 5,200 3,300 5,295 4,059 Restructured loans 8,600 7,200 6,300 6,400 4,300 2,400 2,000 1,800 1,595 1,445...5.25 - - 2,700 900 1,700 200 200 200-2,004 SDR - - - 600 1,500 1,500 2,700 1,000 - - S4A - - - - 300 400 300 300 2,200 610 Other - - - - - - - - 1,500 - July 30, 2018 3

Exhibit 5: SOTP valuation summary Particulars % Valuation Methodology Value/share (`) Value of ICICI standalone 100 1.9x FY20E ABV 306 Subsidiaries ICICI Prudential Life 55 On Current M.Cap 49 General Insurance 56 On Current M.Cap 30 Mutual Fund 51 8% of current AUM 19 Other (Home Fin, VC, Securities PD and Overseas subsidiaries) 33 Total subsidiaries' value @ 20% discount 105 Fair value per share 411 Outlook & Valuation: At the current market price, the bank s core banking business (after adjusting value of subsidiaries) is trading at 1.16x FY20E ABV. We believe strength of liability franchise (CASA-50%), shift in loan mix towards retail assets and better rated companies, Strong capitalization (tier I of 14.42%), and steady improvement in stress loan and going forward quick resolution under IBC would be the key trigger for multiple expansion. We recommend a Buy rating on the stock, with a target price of `411. July 30, 2018 4

Income Statement Y/E March (` cr) FY16 FY17 FY18 FY19E FY20E Net Interest Income 21,224 21,738 23,025 26,781 30,126 - YoY Growth (%) 11 2 6 16 12 Other Income 15,323 19,503 17,419 14,458 15,957 - YoY Growth (%) 26 27 (11) (17 ) 10 Operating Income 36,547 41,241 40,444 41,239 46,083 - YoY Growth (%) 17 13 (2) 2 12 Operating Expenses 12,684 14,754 15,704 17,196 19,812 - YoY Growth (%) 10 16 6 10 15 Pre - Provision Profit 23,863 26,487 24,741 24,042 26,271 - YoY Growth (%) 21 11 (7) -3 9 Prov. & Cont. 11,668 15,207 17,307 15,209 9,820 - YoY Growth (%) 199 30 14 (12) (35) Profit Before Tax 12,196 11,279 7,434 8,833 16,451 - YoY Growth (%) (23) (8) (34) 19 86 Prov. for Taxation 2,469 1,478 789 2,026 4,113 - as a % of PBT 20 13 11 23 25 PAT 9,726 9,802 6,645 6,807 12,339 - YoY Growth (%) (13) 1 (32) 2.4 81 Balance Sheet Y/E March (` cr) FY16 FY17 FY18 FY19E FY20E Equity 1,170 1,171 1,292 1,292 1,292 Reserve & Surplus 88,566 98,780 1,03,868 1,09,592 1,19,463 Net worth 89,736 99,951 1,05,160 1,10,883 1,20,754 Deposits 4,21,426 4,90,039 5,60,975 6,18,036 7,09,211 - Growth (%) 17 16 14 10 15 Borrowings 1,74,807 1,47,556 1,82,859 1,91,026 2,17,938 Other Liab. & Prov. 34,726 34,245 30,195 25,807 40,243 Total Liabilities 7,20,695 7,71,791 8,79,189 9,45,752 10,88,146 Cash Balances 27,106 31,702 33,102 38,523 44,622 Bank Balances 32,763 44,011 51,067 27,689 32,072 Investments 1,60,412 1,61,507 2,02,994 2,21,287 2,55,165 Advances 4,35,264 4,64,232 5,12,395 5,72,419 6,56,863 - Growth (%) 12 7 10 12 15 Fixed Assets 7,577 7,805 7,904 9,390 10,877 Other Assets 57,574 62,535 71,727 76,445 88,547 Total Assets 7,20,695 7,71,791 8,79,189 9,45,752 10,88,146 July 30, 2018 5

Key Ratio Y/E March FY16 FY17 FY18 FY19E FY20E Profitability ratios (%) NIMs 3.3 3.2 3.1 3.2 3.3 Cost to Income Ratio 35 36 39 42 43 RoA 1.4 1.3 0.8 0.7 1.2 RoE 11 10 6 6 11 B/S ratios (%) CASA Ratio 46 50 52 51 51 Credit/Deposit Ratio 1.03 0.95 0.91 0.93 0.93 Asset Quality (%) Gross NPAs 5.2 7.9 8.8 7.0 5.8 Net NPAs 2.7 4.9 3.5 2.8 2.3 Slippages 4.2 7.5 6.4 2.5 2.0 Loan Loss Prov. /Avg. Assets 1.71 2.04 2.10 1.67 0.97 Provision Coverage 50 60 60 60 60 Per Share Data (`) EPS 15 15 10 11 19 ABVPS (75% cover.) 112 116 125 145 161 DPS 5 2 2 2 4 Valuation Ratios PER (x) 20 20 30 29 16 P/ABVPS (x) 2.7 2.6 2.5 2.1 1.9 Dividend Yield (%) 1.5 0.7 0.7 0.7 1.2 DuPont Analysis Int Income 7.7 7.3 6.7 6.8 7.0 Int Exp 4.6 4.3 3.9 3.9 4.1 NII 3.1 2.9 2.8 2.9 3.0 (-) Prov. Exp. 1.7 2.0 2.1 1.7 1.0 Adj. NII 1.4 0.9 0.7 1.3 2.0 Other Inc. 2.2 2.6 2.1 1.6 1.6 Op. Inc. 3.6 3.5 2.8 2.9 3.6 Opex 1.9 2.0 1.9 1.9 1.9 PBT 1.8 1.5 0.9 1.0 1.6 Taxes 0.4 0.2 0.1 0.2 0.4 RoA 1.4 1.3 0.8 0.7 1.2 Leverage 8.0 7.9 8.0 8.4 8.8 RoE 11.4 10.3 6.5 6.3 10.7 Source: Company July 30, 2018 6

Research Team Tel: 022-39357800 E-mail: research@angelbroking.com Website: www.angelbroking.com DISCLAIMER Angel Broking Limited (hereinafter referred to as Angel ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited and Metropolitan Stock Exchange Limited. It is also registered as a Depository Participant with CDSL and Portfolio Manager and Investment Adviser with SEBI. It also has registration with AMFI as a Mutual Fund Distributor. Angel Broking Limited is a registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014 vide registration number INH000000164. Angel or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market. Angel or its associates/analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this document should be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consult their own advisors to determine the merits and risks of such an investment. Reports based on technical and derivative analysis center on studying charts of a stock's price movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on a company's fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate the contrary view, if any The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but we do not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Angel Broking Limited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Angel Broking Limited has not independently verified all the information contained within this document. Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. While Angel Broking Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly. Neither Angel Broking Pvt. Limited, nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connection with the use of this information. Disclosure of Interest Statement ICICI Bank 1. Financial interest of research analyst or Angel or his Associate or his relative No 2. Ownership of 1% or more of the stock by research analyst or Angel or associates or relatives No 3. Served as an officer, director or employee of the company covered under Research No 4. Broking relationship with company covered under Research No Ratings (Based on expected returns Buy (> 15%) Accumulate (5% to 15%) Neutral (-5 to 5%) over 12 months investment period): Reduce (-5% to -15%) Sell (< -15) July 30, 2018 7